Adding Mirabegron to Solifenacin to Treat Overactive Bladder Has Little Impact on Post-Void Residual Volume or Urinary Retention Risk

MJ Drake; S MacDiarmid; S Al-Shukri; J Barkin; A Fianu-Jonasson; S Herschorn; M Huang; M Stoelzel; E Siddiqui

doi:10.1016/j.urology.2017.03.004

Adding Mirabegron to Solifenacin to Treat Overactive Bladder Has Little Impact on Post-Void Residual Volume or Urinary Retention Risk

MJ Drake, S MacDiarmid, S Al-Shukri, J Barkin, A Fianu-Jonasson, S Herschorn, M Huang, M Stoelzel, E Siddiqui

Research output: Contribution to journal › Comment/debate (Academic Journal) › peer-review

7 Citations (Scopus)

774 Downloads (Pure)

Abstract

[no abstract]

Original language	English
Pages (from-to)	1-4
Number of pages	4
Journal	Urology
Volume	104
Early online date	16 Mar 2017
DOIs	https://doi.org/10.1016/j.urology.2017.03.004
Publication status	Published - Jun 2017

Research Groups and Themes

Centre for Surgical Research

Keywords

add-on therapy
mirabegron
solifenacin
overactive bladder
post-void residual volume
urinary retention

Access to Document

10.1016/j.urology.2017.03.004

Full-text PDF (final published version)
This is the final published version of the article (version of record). It first appeared online via Elsevier at http://www.sciencedirect.com/science/article/pii/S0090429517302455. Please refer to any applicable terms of use of the publisher.
Final published version, 196 KBLicence: CC BY

Handle.net

Persistent link

Embargoed Document

PIIS0090429517302455
Accepted author manuscript, 657 KB

Cite this

@article{734366e1166a4f8fb65e9cfe0c62c55f,

title = "Adding Mirabegron to Solifenacin to Treat Overactive Bladder Has Little Impact on Post-Void Residual Volume or Urinary Retention Risk",

abstract = "[no abstract]",

keywords = "add-on therapy, mirabegron, solifenacin, overactive bladder, post-void residual volume, urinary retention",

author = "MJ Drake and S MacDiarmid and S Al-Shukri and J Barkin and A Fianu-Jonasson and S Herschorn and M Huang and M Stoelzel and E Siddiqui",

year = "2017",

month = jun,

doi = "10.1016/j.urology.2017.03.004",

language = "English",

volume = "104",

pages = "1--4",

journal = "Urology",

issn = "0090-4295",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Adding Mirabegron to Solifenacin to Treat Overactive Bladder Has Little Impact on Post-Void Residual Volume or Urinary Retention Risk

AU - Drake, MJ

AU - MacDiarmid, S

AU - Al-Shukri, S

AU - Barkin, J

AU - Fianu-Jonasson, A

AU - Herschorn, S

AU - Huang, M

AU - Stoelzel, M

AU - Siddiqui, E

PY - 2017/6

Y1 - 2017/6

N2 - [no abstract]

AB - [no abstract]

KW - add-on therapy

KW - mirabegron

KW - solifenacin

KW - overactive bladder

KW - post-void residual volume

KW - urinary retention

U2 - 10.1016/j.urology.2017.03.004

DO - 10.1016/j.urology.2017.03.004

M3 - Comment/debate (Academic Journal)

C2 - 28322904

SN - 0090-4295

VL - 104

SP - 1

EP - 4

JO - Urology

JF - Urology

ER -

Adding Mirabegron to Solifenacin to Treat Overactive Bladder Has Little Impact on Post-Void Residual Volume or Urinary Retention Risk

Abstract

Research Groups and Themes

Keywords

Access to Document

Handle.net

Embargoed Document

Fingerprint

Cite this